Physician profile
Aamer Abbas
NPI 1508975772
$26,895.82
in general payments reported to CMS, 2019-2025
27 companies · $492 in 2025
The $492 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $3,670 · 2021: $310 · 2022: $2,900 · 2023: $329 · 2024: $296 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13,188.94 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,598.54 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $2,534.33 | 2019-2022 | |
| Medtronic Vascular, INC. | $512.72 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $332.03 | 2021-2025 | |
| Amgen INC. | $206.73 | 2019-2024 | Repatha |
| Medtronic, INC. | $202.17 | 2021-2022 | |
| Terumo Medical Corporation | $198.17 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $184.08 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $178.99 | 2019 | |
| Philips North America LLC | $108.91 | 2023-2025 | Ecc Solutions, (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $90.65 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $86.59 | 2021-2023 | Verquvo |
| Shockwave Medical, INC | $81.67 | 2022-2025 | |
| Abiomed | $54.86 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.87 | 2024-2025 | Jardiance |
| Amarin Pharma, INC. | $44.04 | 2020-2021 | |
| Abbott Laboratories | $32.80 | 2019 | |
| Scpharmaceuticals INC. | $32.69 | 2024-2025 | |
| Cardiovascular Systems INC. | $31.56 | 2020-2021 | |
| Acist Medical Systems, INC. | $31.46 | 2022 | |
| Boston Scientific Corporation | $25.98 | 2021 | |
| Irhythm Technologies, INC. | $25.40 | 2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $17.41 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.00 | 2021 | |
| Biotronik INC. | $14.87 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamer Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.